COMMUNIQUÉS West-GlobeNewswire

Faron Pharmaceuticals Oy: Faron announces that US FDA proposes proceeding directly to BLA submission for Traumakine® following completion of European and Japanese Phase III studies
04/09/2017
Faron Pharmaceuticals Ltd ("Faron" or the "Company") Faron announces that US FDA proposes proceeding directly to BLA submission for Traumakine ® following completion of European and Japanese Phase III studies TURKU - [...]
Midatech Pharma Plc: Midatech submits MTD201 CTA filing for first in human study in carcinoid cancer and acromegaly
04/09/2017
4 September 2017 Midatech Pharma PLC ("Midatech", "Company" or "Group") Midatech submits MTD201 CTA filing for first in human study in carcinoid cancer and acromegaly Midatech on track to start clinical development with [...]
Solon Eiendom ASA - Primary insider notification
04/09/2017
SOLON EIENDOM ASA STOCK EXCHANGE ANNOUNCEMENT Solon Eiendom ASA - Primary insider notification (Oslo, Norway, 4 September 2017) Solon Eiendom ASA Chairman of the Board Simen Thorsen (through his wholly owned company [...]
Affimed to Present at the 2017 Wells Fargo Healthcare Conference - Boston
04/09/2017
Heidelberg, Germany, September 4, 2017 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that Dr. Adi [...]
Novartis announces CEO Joseph Jimenez to retire from Novartis in 2018. Vasant Narasimhan appointed CEO, effective February 1, 2018.
04/09/2017
Basel, September 4, 2017 - Joseph Jimenez, Chief Executive Officer (CEO) of Novartis, has informed the Board of Directors of his desire to step down as CEO in 2018, after eight years in position. The Board of Directors [...]
Bone Therapeutics SA: The preliminary documents for the Extraordinary General Shareholder Meeting on 5 October 2017 have been made available
04/09/2017
Regulated information The preliminary documents for the Extraordinary General Shareholder Meeting on 5 October 2017 have been made available Gosselies, Belgium, 4 September 2017, 7am CEST - BONE THERAPEUTICS (Euronext [...]
Bone Therapeutics SA : Mise à disposition des documents préparatoires à l'assemblée générale extraordinaire du 5 octobre 2017
04/09/2017
Information réglementée Mise à disposition des documents préparatoires à l'assemblée générale extraordinaire du 5 octobre 2017 Gosselies, Belgique, le 4 septembre 2017, 7h CEST - BONE THERAPEUTICS (code Euronext [...]
Novartis annonce que son Directeur général, Joseph Jimenez, a décidé de quitter la société en 2018. Vasant Narasimhan est nommé Directeur général, à compter du 1er février 2018.
04/09/2017
Bâle, le 4 septembre 2017 - Joseph Jimenez, Directeur général (CEO) de Novartis, a informé le Conseil d'administration de son souhait de quitter ses fonctions de Directeur général en 2018, après avoir occupé ce poste [...]
Data Published in The Lancet Shows Positive Results at Primary Endpoint in the Treatment of Resistant Hypertension with MobiusHD Device
02/09/2017
Publication Follows Positive Interim Results in US and EU Patients Presented at the European Society of Cardiology Conference MOUNTAIN VIEW, Calif., Sept. 01, 2017 (GLOBE NEWSWIRE) -- Vascular Dynamics, Inc. (VDI), a [...]
Taconic Biosciences sponsorise un modèle personnalisé pour la prise en charge du syndrome de Kabuki, une maladie rare qui entraîne un déficit intellectuel
01/09/2017
HUDSON, New York, le 31 août 2017 (GLOBE NEWSWIRE) - Taconic Biosciences, leader mondial en matière de modèles de rongeurs génétiquement modifiés et de services associés, finance le développement d'un modèle de souris [...]
Diaxonhit : Prise d'effet du regroupement d'actions par 20
01/09/2017
Prise d'effet du regroupement d'actions DIAXONHIT Modalités du regroupement d'actions: regroupement par voie d'échange à raison de 1 action nouvelle regroupée contre 20 actions anciennes Les actions nouvelles ont été [...]
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
01/09/2017
FIT Biotech Oy Company release September 1, 2017 at 4:00 pm FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants On September 26, 2016, the Board of Directors of FIT Biotech Oy [...]
Shire plc : Total voting rights
01/09/2017
Total Voting Rights September 1, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in accordance with 5.6.1R of the Financial Conduct Authority's (the "FCA") Disclosure Guidance and Transparency Rules, notifies [...]
Zealand increases its share capital as a consequence of exercise of employee warrants
01/09/2017
Company announcement - No. 43 / 2017 Zealand increases its share capital as a consequence of exercise of employee warrants Copenhagen, September 1, 2017 - Zealand has increased its share capital by a nominal amount of [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
01/09/2017
FIT Biotech Oy Company release September 1, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]
Changes in Amer Sports leadership team
01/09/2017
Amer Sports Corporation STOCK EXCHANGE RELEASE September 1, 2017 at 10:00 a.m. Changes in Amer Sports leadership team Bernard Millaud, President of Cycling and a member of Amer Sports Executive Board has decided to step [...]
Notice of extraordinary general meeting in Aino Health AB (publ.)
01/09/2017
The shareholders in Aino Health AB (publ) reg. no. 559063-5073 (the "Company") are hereby convened to the extraordinary general meeting on Tuesday October 3, 2017, at 05:00 p.m. at Grand Hotel, Bantorget 1, 222 29 Lund [...]
Aino Health AB (publ): proposes changes to the Board
01/09/2017
Aino Health AB gears its Board's expertise by nominating Liselotte Bergmark as a new Board member, to be elected at an extraordinary general meeting. Liselotte Bergmark will provide the Board with international branch [...]
Verona Pharma Appoints Stifel as Nominated Adviser
01/09/2017
LONDON, Sept. 01, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]

Pages